Advertisement
Research ArticleMinireview
Open Access

The Pharmacological Case for Cannabigerol

Rahul Nachnani, Wesley M. Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics February 2021, 376 (2) 204-212; DOI: https://doi.org/10.1124/jpet.120.000340

Article Information

vol. 376 no. 2 204-212
DOI 
https://doi.org/10.1124/jpet.120.000340
PubMed 
33168643
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received September 15, 2020
  • Accepted November 4, 2020
  • Published online January 19, 2021.

Article Versions

Copyright & Usage 
Copyright © 2021 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.

Author Information

  1. Rahul Nachnani,
  2. Wesley M. Raup-Konsavage, and
  3. Kent E. Vrana
  1. Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania
  1. Address correspondence to:
    Kent E. Vrana, Penn State College of Medicine, 500 University Dr., Hershey, PA 17033. E-mail: kvrana{at}pennstatehealth.psu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2020 to June 2021

AbstractFullPdf
Nov 20203790265
Dec 20202810168
Jan 2021263710262
Feb 2021248790198
Mar 20212341136523
Apr 2021226600260
May 2021165819278
Jun 2021149719183

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMinireview

Potential Clinical Uses of CBG

Rahul Nachnani, Wesley M. Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics February 1, 2021, 376 (2) 204-212; DOI: https://doi.org/10.1124/jpet.120.000340
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement